Malate dehydrogenase‐2 inhibition shields renal tubular epithelial cells from anoxia‐reoxygenation injury by reducing reactive oxygen species
Journal of Biochemical and Molecular Toxicology · 2024
DOI: 10.1002/jbt.23854 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Georgios Pissas und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa, Greece. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Epithelial Cells, Malate Dehydrogenase. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Ischemia‐reperfusion (I‐R) injury is the most common cause of acute kidney injury. In experiments involving primary human renal proximal tubular epithelial cells (RPTECs) exposed to anoxia‐reoxygenation, we explored the hypothesis that mitochondrial malate dehydrogenase‐2 (MDH‐2) inhibition redirects malate metabolism from the mitochondria to the cytoplasm, towards the malate‐pyruvate cycle and reversed malate‐aspartate shuttle. Colorimetry, fluorometry, and western blotting showed that MDH2 inhibition accelerates the malate‐pyruvate cycle enhancing cytoplasmic NADPH, thereby regenerating the potent antioxidant reduced glutathione. It also reversed the malate‐aspartate shuttle and potentially diminished mitochondrial reactive oxygen species (ROS) production by transferring electrons, in the form of NADH, from the mitochondria to the cytoplasm. The excessive ROS production induced by anoxia‐reoxygenation led to DNA damage and protein modification, triggering DNA damage and unfolded protein response, ultimately resulting in apoptosis and senescence. Additionally, ROS induced lipid peroxidation, which may contribute to the process of ferroptosis. Inhibiting MDH‐2 proved effective in mitigating ROS overproduction during anoxia‐reoxygenation, thereby rescuing RPTECs from death or senescence. Thus, targeting MDH‐2 holds promise as a pharmaceutical strategy against I‐R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Faculty of Medicine, University of Thessaly, Larissa, Greece.
Zitieren
APA
Pissas, G., Tziastoudi, M., Divani, M., Poulianiti, C., Konsta, M. A. P., Lykotsetas, E., Liakopoulos, V., Stefanidis, I., & Eleftheriadis, T. (2024). Malate dehydrogenase‐2 inhibition shields renal tubular epithelial cells from anoxia‐reoxygenation injury by reducing reactive oxygen species. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23854
Vancouver
Pissas G, Tziastoudi M, Divani M, Poulianiti C, Konsta MAP, Lykotsetas E, et al. Malate dehydrogenase‐2 inhibition shields renal tubular epithelial cells from anoxia‐reoxygenation injury by reducing reactive oxygen species. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23854
BibTeX
@article{Pissas2024,
author = {Pissas, Georgios and Tziastoudi, Maria and Divani, Maria and Poulianiti, Christina and Konsta, Maria Anna Polyzou and Lykotsetas, Evangelos and Liakopoulos, Vasilios and Stefanidis, Ioannis and Eleftheriadis, Theodoros},
title = {Malate dehydrogenase‐2 inhibition shields renal tubular epithelial cells from anoxia‐reoxygenation injury by reducing reactive oxygen species},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2024},
doi = {10.1002/jbt.23854}
}
EUVIMED